Recombinant live Salmonella spp. for human vaccination against heterologous pathogens
D Bumann, C Hueck, T Aebischer… - FEMS Immunology & …, 2000 - academic.oup.com
FEMS Immunology & Medical Microbiology, 2000•academic.oup.com
Live attenuated Salmonella spp. are promising candidates as oral vaccine delivery systems
for heterologous antigens. Clinical trials have demonstrated that this approach is feasible for
human vaccinations but further optimisation is necessary to obtain a better efficacy. Here, we
discuss how existing clinical and pre-clinical data can be used to guide such optimisation
efforts.
for heterologous antigens. Clinical trials have demonstrated that this approach is feasible for
human vaccinations but further optimisation is necessary to obtain a better efficacy. Here, we
discuss how existing clinical and pre-clinical data can be used to guide such optimisation
efforts.
Abstract
Live attenuated Salmonella spp. are promising candidates as oral vaccine delivery systems for heterologous antigens. Clinical trials have demonstrated that this approach is feasible for human vaccinations but further optimisation is necessary to obtain a better efficacy. Here, we discuss how existing clinical and pre-clinical data can be used to guide such optimisation efforts.
Oxford University Press